0001181431-13-006301.txt : 20130204
0001181431-13-006301.hdr.sgml : 20130204
20130204135747
ACCESSION NUMBER: 0001181431-13-006301
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130131
FILED AS OF DATE: 20130204
DATE AS OF CHANGE: 20130204
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bahrt Kenneth
CENTRAL INDEX KEY: 0001527197
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-15313
FILM NUMBER: 13569323
MAIL ADDRESS:
STREET 1: ONE TOWER CENTER BLVD
CITY: EAST BRUNSWICK
STATE: NJ
ZIP: 08619
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SAVIENT PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000722104
STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
IRS NUMBER: 133033811
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE TOWER CENTER
CITY: EAST BRUNSWICK
STATE: NJ
ZIP: 08816
BUSINESS PHONE: 7324189300
MAIL ADDRESS:
STREET 1: ONE TOWER CENTER
CITY: EAST BRUNSWICK
STATE: NJ
ZIP: 08816
FORMER COMPANY:
FORMER CONFORMED NAME: BIO TECHNOLOGY GENERAL CORP
DATE OF NAME CHANGE: 19920703
4
1
rrd368607.xml
BAHRT FORM 4
X0306
4
2013-01-31
0
0000722104
SAVIENT PHARMACEUTICALS INC
SVNT
0001527197
Bahrt Kenneth
400 CROSSING BLVD.
3RD FLOOR
BRIDGEWATER
NJ
08807
0
1
0
0
SVP, Chief Medical Officer
Common Stock $.01 par value per share
2013-01-31
4
S
0
1300
1.03
D
200750
D
These shares were sold automatically pursuant to a binding contract under Rule 10b5-1 of the Securities Exchange Act of 1934 to cover tax witholding obligations in connection with the vesting of restricted stock granted on July 31, 2011
/s/ Philip K. Yachmetz as attorney-in-fact for Kenneth Bahrt
2013-02-04